Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Background: Diabetes is a risk factor associated with pancreatic ductal adenocarcinoma (PDAC), and new adult-onset diabetes can be an early sign of pancreatic malignancy. Development of blood-based biomarkers to identify diabetic patients who warrant imaging tests for cancer detection may represent...

Full description

Bibliographic Details
Main Authors:	Hong Peng, Sheng Pan, Yuanqing Yan, Randall E. Brand, Gloria M. Petersen, Suresh T. Chari, Lisa A. Lai, Jimmy K. Eng, Teresa A. Brentnall, Ru Chen
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Cancers
Subjects:	proteomics pancreatic cancer pancreatic ductal adenocarcinoma diabetes mass spectrometry plasma
Online Access:	https://www.mdpi.com/2072-6694/12/6/1534

Similar Items

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01)

Proteome-Wide Alterations of Asymmetric Arginine Dimethylation Associated With Pancreatic Ductal Adenocarcinoma Pathogenesis
by: Meijin Wei, et al.
Published: (2020-12-01)

Diagnosis of the pancreatic cancer
by: Przemysław Raczkiewicz, et al.
Published: (2021-09-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
by: Wu-Hu Zhang, et al.
Published: (2020-01-01)

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
by: Sumit Sahni, et al.
Published: (2020-03-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
by: Yolanda Rodríguez Gil, et al.
Published: (2021-02-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
by: Sahar Ghassem-Zadeh, et al.
Published: (2017-06-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

Regulation of pancreatic stellate cell activation by Notch3
by: Haiyan Song, et al.
Published: (2018-01-01)

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
by: John C. Chang, et al.
Published: (2017-03-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
by: Marwa Elsayed, et al.
Published: (2021-04-01)

Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells
by: Sarah B. Gitto, et al.
Published: (2020-06-01)

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
by: Balbina García-Reyes, et al.
Published: (2018-10-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing
by: Wenli Zhou, et al.
Published: (2021-05-01)

Mercury in Pancreatic Cells of People with and without Pancreatic Cancer
by: Roger Pamphlett, et al.
Published: (2020-12-01)

Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
by: Yuanyuan Xiao, et al.
Published: (2019-08-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
by: Chuangen Guo, et al.
Published: (2018-10-01)

A Silent Asymptomatic Solid Pancreas Tumor in a Nonsmoking Athletic Female: Pancreatic Ductal Adenocarcinoma
by: Kyawzaw Lin, et al.
Published: (2017-10-01)

Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
by: Ruben Verloy, et al.
Published: (2020-09-01)

The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress
by: Mugahed Abdullah Hasan Albahde, et al.
Published: (2021-05-01)

Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors
by: Naru Kim, et al.
Published: (2020-01-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
by: Sara Palchetti, et al.
Published: (2019-01-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
by: Debang Li, et al.
Published: (2018-10-01)

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
by: Daniela Massihnia, et al.
Published: (2017-01-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
by: Quisette P. Janssen, et al.
Published: (2020-01-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)